Modulation of antigen delivery and lymph node activation in non-human primates by saponin adjuvant SMNP.
Ontology highlight
ABSTRACT: Saponin-based vaccine adjuvants are potent in preclinical animal models and humans, but their mechanisms of action remain poorly understood. Here, using a stabilized HIV envelope trimer immunogen, we carried out studies in non-human primates (NHPs) comparing the most common clinical adjuvant alum with Saponin/MPLA Nanoparticles (SMNP), a novel ISCOMs-like adjuvant. SMNP elicited substantially stronger humoral immune responses than alum, including 7-fold higher peak antigen-specific germinal center B cell responses, 18-fold higher autologous neutralizing antibody titers, and higher levels of antigen-specific plasma and memory B cells. PET-CT imaging in live NHPs showed that, unlike alum, SMNP promoted rapid antigen accumulation in both proximal and distal lymph nodes (LNs). SMNP also induce
SUBMITTER: Yousefpour P
PROVIDER: S-EPMC11383317 | biostudies-literature | 2024 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA